• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

4.220 -0.070 (-1.63%)
Streaming Delayed Price Updated: 10:15 AM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,048
Open 4.220
Bid (Size) 3.900 (300)
Ask (Size) 4.250 (100)
Prev. Close 4.290
Today's Range 3.950 - 4.250
52wk Range 1.900 - 12.36
Shares Outstanding 620,290
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment
June 23, 2026
Via Investor Brand Network
Study Links TBI to Higher Mortality Risk Due to Brain Cancer
June 12, 2026
Via Investor Brand Network

Performance

YTD
-20.4%
-20.4%
1 Month
-19.2%
-19.2%
3 Month
+55.7%
+55.7%
6 Month
-32.3%
-32.3%
1 Year
-53.7%
-53.7%

More News

Read More
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation
June 08, 2026
Via Investor Brand Network
Collagen Tiles Could Prevent Brain Cancer Recurrence
June 08, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
June 08, 2026
Via ACCESS Newswire
Pediatric Brain Tumors Spread Faster as Immune Cells Build Enabling Scaffolding
June 04, 2026
Via Investor Brand Network
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment
May 27, 2026
Via Investor Brand Network
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment
May 26, 2026
Via Investor Brand Network
Which stocks are moving before the opening bell on Tuesday? ↗
May 26, 2026
Via Chartmill
Study Finds That Errors in Brain Cell Division Could Trigger Cancer
May 22, 2026
Via Investor Brand Network
Study Suggests Testosterone Slows Glioblastoma Progression in Men
May 14, 2026
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation
May 14, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
May 14, 2026
Via ACCESS Newswire
Blocking Fructose Metabolism Boosts Immune Response to Childhood Cancer
May 06, 2026
Via Investor Brand Network
Immunologists Discover How Cancer Reprograms Immune Cells to Support Cancer Growth
May 05, 2026
Via Investor Brand Network
Wondering what's happening in today's pre-market session? ↗
May 05, 2026
Via Chartmill
NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $22.5 Million Private Placement Financing
May 04, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
May 04, 2026
Via ACCESS Newswire
Study Finds Exercise, Ibuprofen Combat Brain Fog in Cancer Patients
April 28, 2026
Via Investor Brand Network
New Molecule May Open New Therapeutic Pathway Against Brain Cancer
April 27, 2026
Via Investor Brand Network
Why Molecular Testing is Increasingly Important in CNS Cancers
April 21, 2026
Via Investor Brand Network
Scientists Discover Brain Cells That Aid Brain Cancer Development
April 15, 2026
Via Investor Brand Network
Preclinical Study Reveals Promising Treatment for Glioblastoma
April 14, 2026
Via Investor Brand Network
Study Explores Whether a Common Vitamin Could Fight Brain Cancer
April 07, 2026
Via Investor Brand Network
Researchers Solve 50-Year-Old Challenge in Making Cancer Drug
April 01, 2026
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 4.220
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 06/24/26 10:15 AM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 2.62M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap